Form 4: Guardant Health CFO Acquires Shares

Guardant Health's Chief Financial Officer, Michael Brian Bell, acquired shares through the vesting of restricted stock units and retained shares for tax withholding.

Summary

• Michael Brian Bell, Chief Financial Officer of Guardant Health, Inc., reported transactions on July 1, 2026.
• Bell acquired 2,084 shares of common stock through the vesting of restricted stock units (RSUs) granted on December 13, 2023.
• An additional 3,324 shares were acquired through the vesting of RSUs granted on November 8, 2024.
• Furthermore, 1,870 shares were acquired through the vesting of RSUs granted on March 12, 2025.
• Bell also had 3,914 shares retained by the company to cover tax withholding obligations related to RSU vesting, disposed of at a price of $170.77 per share.
• Following these transactions, Bell beneficially owns 50,536 shares directly, with the total number of shares owned after reported transactions being 55,730.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it primarily reports on routine insider transactions related to executive compensation and does not contain new strategic information or significant financial performance indicators.

Positives

• The Chief Financial Officer continues to hold a significant number of shares, indicating confidence in the company.
• Vesting of restricted stock units suggests that performance or service conditions have been met.
• The acquisition of shares through RSUs is a common form of executive compensation, aligning management interests with shareholders.

Negatives

• A portion of shares (3,914) were retained by the company for tax withholding, which represents a disposition of shares from the executive's direct ownership.
• The disposal price of $170.77 for the tax-withheld shares might indicate a valuation point at the time of vesting.

Risks

• The filing does not explicitly mention any new risks or challenges.
• The retention of shares for tax withholding is a standard procedure but represents a reduction in the executive's direct shareholding.

Future Outlook

The filing primarily reports on past transactions and does not contain forward-looking statements or guidance.

Management Comments

• The filing includes a signature by John G. Saia, as attorney-in-fact for Michael Brian Bell, indicating delegation for the filing.
• Explanations detail the nature of the restricted stock unit awards, their vesting schedules, and the purpose of share retention for tax withholding.

Industry Context

StockSavvy.ai notes that Form 4 filings are standard for tracking insider transactions, including the acquisition of shares through equity compensation plans like Restricted Stock Units (RSUs). This type of filing is common in the biotechnology and healthcare sectors where equity-based compensation is prevalent.

Stakeholder Impact

• Shareholders: The transactions reflect the standard compensation practices for executives and do not immediately indicate a change in beneficial ownership beyond what is expected from equity awards.
• Employees: The vesting of RSUs for the CFO is part of the company's compensation strategy, which can influence employee morale and retention.
• Management: The CFO is continuing to acquire equity through vested awards, aligning personal financial interests with the company's performance.

Next Steps

• Continued vesting of remaining portions of the restricted stock unit awards according to their schedules.
• Ongoing reporting of any future transactions by Michael Brian Bell as required by SEC regulations.

Key Dates

Keywords

Guardant Health, GH, Form 4, SEC Filing, Insider Transaction, Stock Vesting, Restricted Stock Units, RSU, Michael Brian Bell, Chief Financial Officer, Beneficial Ownership, Tax Withholding